Patent · US Active

Compounds for the treatment and prophylaxis of respiratory syncytial virus disease

US8604019B2 · kind B2 · utility

1Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 10, 2012
Grant dateDec 10, 2013
Priority date
Expiry dateOct 10, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the compounds of formula (I):and pharmaceutically acceptable salts thereof, wherein R1, R2 and X are as defined in the description and claims, which are useful for the treatment or prophylaxis of RSV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.